Niagen Bioscience (NAGE) formerly ChromaDex Corp announced the broadening of its NAD+ precursor intellectual property or IP portfolio with the ...
Some scientists, including Sinclair, believe that boosting the body’s stores with a NAD supplement is a promising way to slow ...
NAD infusions are just one of the latest crazes for longevity-seekers, but can it really help you live longer? Here’s what an ...
NAD+ boosters can affect how certain medications like insulin, blood pressure lowering, antidepressants, and cancer ...
Scientific research continues to be central to ChromaDex’s growth strategy, with the company putting a good deal of money into advancing NAD precursor innovation. One of the more closely watched ...
Recent research has homed in on diet and exercise as key factors when it comes to slowing down biological aging and boosting ...
Impaired yolk sac NAD metabolism disrupts murine embryogenesis with relevance to human birth defects
Furthermore, diminished NAD de novo synthesis in the yolk sac is responsible for the defects caused by our 3-day precursor restriction, because the embryonic liver has not yet formed. These data ...
Impaired yolk sac NAD metabolism disrupts murine embryogenesis with relevance to human birth defects
This study builds on the observation that the kynurenine pathway is required in the conceptus, as HAAO null embryos are sensitive to maternal deficiency of NAD precursors (vitamin B3) and tryptophan, ...
State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Wuhan 430070, China Hubei Longzhong Laboratory, Wuhan University of Technology ...
Q4 2024 Earnings Call Transcript March 4, 2025 ChromaDex Corporation beats earnings expectations. Reported EPS is $0.09, expectations were $0.02. Operator: Ladies and gentlemen, thank you for standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback